MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2018 International Congress

    Improving clinical data collection at patients’ home in Parkinson’s disease: The Sleep Fit app

    A. Mascheroni, C. Ferlito, S. Hackethal, S. Caverzasio, E-K. Choe, Y. Luo, F. Faraci, A. Kaelin-Lang, A. Puiatti, P-L. Ratti, M. Marazza (Manno, Switzerland)

    Objective: We introduce Sleep Fit, the first tablet application to collect subjective and objective clinical data especially designed for patients with Parkinson’s Disease (PD). Background:…
  • 2018 International Congress

    Item Response Theory Analysis of the Unified Dyskinesia Rating Scale Items

    C. Goetz, S. Luo, G. Stebbins (Chicago, IL, USA)

    Objective: To investigate the measurement characteristics of the Unified Dyskinesia Rating Scale (UDysRS) using item response theory (IRT) approaches. Background: The UDysRS has become the…
  • 2018 International Congress

    A Phase 3 study of isradipine as a disease modifying agent in patients with early Parkinson disease(STEADY-PD III): Baseline characteristics and study update

    R. Holloway, D. Oakes, T. Simuni, K. Hodgeman, B. Greco, S. Henderson, J. Lowell, S. Sharma, C. Tarolli, K. Biglan (Rochester, NY, USA)

    Objective: To evaluate the efficacy of isradipine 10 mg daily on Parkinson disease (PD) disability. Background: Isradipine, a dihydropyridine calcium channel antagonist with excellent penetration…
  • 2018 International Congress

    Objective assessment of Parkinson’s disease motor symptoms during leg agility test using motion sensors

    S. Aghanavesi, M. Memedi, M. Senek, D. Nyholm, F. Bergquist (Borlange, Sweden)

    Objective: To develop and evaluate machine learning methods for assessment of Parkinson’s disease (PD) motor symptoms using leg agility (LA) data collected with motion sensors…
  • 2018 International Congress

    Validity And Reliability Of Nineteen-Item Wearing-Off Questionnaire In Turkish Patients

    H. Çotur Levent, AY. Yılmaz, MC. Akbostancı (Ankara, Turkey)

    Objective: To conduct the validity and reliability study of the Turkish version of nineteen-item wearing-off (WO19)questionnaire. Background: Wearing-off(WO)is probably the most frequent motor complication of…
  • 2018 International Congress

    Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial

    M. Schwarzschild, E. Macklin, R. Bakshi, S. Bhattacharyya,, R. Logan, A. Ascherio; on behalf of the Parkinson Study Group SURE-PD Investigators (Boston, MA, USA)

    Objective: To investigate whether women and men with Parkinson's disease (PD) may differ in their biochemical and clinical responses to long-term treatment with urate-elevating inosine.…
  • 2018 International Congress

    Prospective, home-based assessment of motor symptoms in Parkinson’s disease by mean of the Sleep Fit app: A potential new clinical approach

    P-L. Ratti, F. Faraci, A. Mascheroni, S. Hackethal, C. Ferlito, S. Caverzasio, E-K. Choe, Y. Luo, P-E. Nunes Ferreira, A. Puiatti, A. Kaelin-Lang (Lugano, Switzerland)

    Objective: To investigate the correspondence between subjective data on motor symptoms prospectively collected at home and retrospective, subjective data assessed by structured interview in patients…
  • 2018 International Congress

    Pediatric Tics and DCD: Motor Network Disorders?

    M. Kuiper, R. Brandsma, W. Eggink, M. Egmond, J. de Vries, P. Hoekstra, A. Dietrich, D. Sival (Groningen, Netherlands)

    Objective: To characterize and quantify pediatric tics and DCD according to specific movement disorder features. Background: Until now, it has been impossible to attribute the…
  • 2018 International Congress

    Motivators, Barriers and Clinical Correlates of Physical Activity in Parkinson Disease

    S. Mantri, S. Wood, J. Duda, J. Morley (Philadelphia, PA, USA)

    Objective: To characterize physical activity levels as well as barriers and motivators for exercise in US military Veterans with Parkinson disease (PD). Background: Physical activity…
  • 2018 International Congress

    A New Scale to Measure Impairment in Patients with Writer’s Cramp

    E. Shamim, O. Ahmad, T. Wu, P. Srivanitchapoom, P. Diomi, B. Karp, K. Alter, C. Toro, B. Hodsdon, S. Pandey, J. Park, S. Meunier, M. Hallett (Largo, MD, USA)

    Objective: To validate a new writer’s cramp impairment scale (WCIS) and compare it with an existing writer’s cramp rating scale (WCRS) Background: Writer’s cramp (WC)…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28953 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley